NATCOPHARM / NSE / Biotechnology & Drugs

Natco Pharma

INR 893.429.50 (-2.75%) 1D

Last updated: 2026-06-16T07:59:28.979776+00:00

Price Chart

1Y Price Trend

Open917.05

High1,226.8

Low789

Close847.6

Volume15,06,650

Change-69.45

Change %-7.57%

Key Information

Ticker SymbolNATCOPHARM

Current Price893.4

52-Week High1,226.8

52-Week Low789

Market Cap16,115.41

Beta0.74

Volume15,06,650

ISININE987B01026

Day High889

Day Low839.5

Open883

Recommendations

RatingHold

Target High1,226.1

Target Low789.3

Target Mean2.89

Target Median36.11

Risk Metrics

Overall RiskBalanced risk

Board Risk44.41

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Compulsory License || Bayer Coporation Vs Natco Pharma||Lee Pharma Vs Astrazenca||F.Hoffmann V Cipla Lens Vs Psg (tY9j6BNO86) - Fathom Journal3 days ago

Market news

Compulsory License || Bayer Coporation Vs Natco Pharma||Lee Pharma Vs Astrazenca||F.Hoffmann V Cipla Lens Vs Psg (tY9j6BNO86) Fathom Journal

Kaynes Technology and 3 Other Stocks Falling Due to Weak Q4 Results - Trade Brains4 days ago

Market news

Kaynes Technology and 3 Other Stocks Falling Due to Weak Q4 Results Trade Brains

Natco Pharma shares sink up to 15% after weak Q4 earnings - MSN8 days ago

Market news

Natco Pharma shares sink up to 15% after weak Q4 earnings MSN

Natco Pharma shares slump 15% after Q4 results; here's why the stock is falling - MSN14 days ago

Market news

Natco Pharma shares slump 15% after Q4 results; here's why the stock is falling MSN

Natco Pharma FY26 profit falls 25%; Q4 EBITDA margin at 25.1% - scanx.trade15 days ago

Market news

Natco Pharma FY26 profit falls 25%; Q4 EBITDA margin at 25.1% scanx.trade

Lupin and Natco Secure US FDA Approval for Generic Eribulin Mesylate Injection - Machine Maker15 days ago

Market news

Lupin and Natco Secure US FDA Approval for Generic Eribulin Mesylate Injection Machine Maker

Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection - IndiaMedToday15 days ago

Market news

Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection IndiaMedToday

Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63% - Business Upturn15 days ago

Market news

Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63% Business Upturn

FAQ

Stock FAQs

What is the NSE symbol for Natco Pharma?

Natco Pharma trades on NSE with the symbol NATCOPHARM. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Natco Pharma share price and chart?

You can track Natco Pharma share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Natco Pharma?

Yes. ShareKeyX displays available financial statements for Natco Pharma using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Natco Pharma?

Yes. ShareKeyX displays available historical OHLC candles for Natco Pharma across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Natco Pharma belong to?

Natco Pharma is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Natco Pharma?

Yes. ShareKeyX shows the latest available stock news for Natco Pharma from the connected stock news source.